Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 10 | 2025 | 969 | 2.600 |
Why?
|
| Formaldehyde | 2 | 2024 | 5 | 1.750 |
Why?
|
| Survivors | 6 | 2016 | 157 | 1.500 |
Why?
|
| Continuity of Patient Care | 6 | 2020 | 103 | 1.480 |
Why?
|
| Delivery of Health Care, Integrated | 6 | 2023 | 535 | 1.480 |
Why?
|
| Neoplasms | 8 | 2023 | 446 | 1.370 |
Why?
|
| Biomarkers, Tumor | 3 | 2016 | 145 | 1.320 |
Why?
|
| Medical Oncology | 6 | 2023 | 32 | 1.290 |
Why?
|
| Papillomavirus Infections | 4 | 2025 | 142 | 1.240 |
Why?
|
| Diagnostic Imaging | 3 | 2018 | 42 | 1.110 |
Why?
|
| Depression | 3 | 2023 | 486 | 1.010 |
Why?
|
| Mass Screening | 6 | 2025 | 672 | 1.000 |
Why?
|
| Colorectal Neoplasms | 5 | 2024 | 622 | 0.990 |
Why?
|
| Tissue Fixation | 1 | 2024 | 3 | 0.890 |
Why?
|
| Chromatin | 1 | 2024 | 5 | 0.890 |
Why?
|
| Museums | 2 | 2024 | 2 | 0.880 |
Why?
|
| Early Detection of Cancer | 7 | 2025 | 529 | 0.870 |
Why?
|
| Genome, Mitochondrial | 1 | 2024 | 2 | 0.860 |
Why?
|
| Humans | 37 | 2025 | 17314 | 0.830 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2016 | 302 | 0.820 |
Why?
|
| Female | 23 | 2025 | 12396 | 0.730 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2025 | 131 | 0.730 |
Why?
|
| Referral and Consultation | 2 | 2022 | 157 | 0.710 |
Why?
|
| Community Health Services | 1 | 2022 | 79 | 0.700 |
Why?
|
| Papillomavirus Vaccines | 1 | 2022 | 114 | 0.700 |
Why?
|
| Medical Overuse | 2 | 2018 | 14 | 0.700 |
Why?
|
| Patient Portals | 1 | 2021 | 23 | 0.680 |
Why?
|
| Epigenomics | 1 | 2020 | 5 | 0.650 |
Why?
|
| Population Surveillance | 3 | 2016 | 252 | 0.640 |
Why?
|
| Guideline Adherence | 3 | 2015 | 149 | 0.630 |
Why?
|
| Middle Aged | 17 | 2025 | 7836 | 0.630 |
Why?
|
| Neoplasm Staging | 6 | 2023 | 338 | 0.540 |
Why?
|
| Practice Guidelines as Topic | 3 | 2016 | 310 | 0.530 |
Why?
|
| Lung Neoplasms | 2 | 2017 | 268 | 0.500 |
Why?
|
| Unnecessary Procedures | 1 | 2015 | 21 | 0.490 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 53 | 0.480 |
Why?
|
| DNA | 2 | 2025 | 23 | 0.450 |
Why?
|
| Perception | 2 | 2024 | 56 | 0.450 |
Why?
|
| Aged | 14 | 2024 | 6084 | 0.450 |
Why?
|
| Patient Care Planning | 3 | 2016 | 45 | 0.450 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2014 | 68 | 0.420 |
Why?
|
| Social Support | 2 | 2016 | 207 | 0.420 |
Why?
|
| California | 8 | 2025 | 2311 | 0.420 |
Why?
|
| Quality of Health Care | 4 | 2018 | 259 | 0.420 |
Why?
|
| Health Maintenance Organizations | 1 | 2015 | 407 | 0.410 |
Why?
|
| Adult | 12 | 2025 | 7500 | 0.400 |
Why?
|
| Surveys and Questionnaires | 6 | 2024 | 1282 | 0.390 |
Why?
|
| Male | 11 | 2024 | 9804 | 0.390 |
Why?
|
| Health Services Research | 3 | 2019 | 202 | 0.380 |
Why?
|
| Rehabilitation | 1 | 2012 | 2 | 0.380 |
Why?
|
| Physicians | 1 | 2013 | 117 | 0.370 |
Why?
|
| Delivery of Health Care | 5 | 2022 | 390 | 0.320 |
Why?
|
| Aftercare | 3 | 2020 | 47 | 0.310 |
Why?
|
| Oncology Nursing | 1 | 2008 | 2 | 0.300 |
Why?
|
| Patient Care | 2 | 2019 | 29 | 0.290 |
Why?
|
| Documentation | 1 | 2008 | 40 | 0.280 |
Why?
|
| Patient Care Management | 1 | 2008 | 25 | 0.280 |
Why?
|
| Electronic Health Records | 5 | 2023 | 704 | 0.280 |
Why?
|
| Quality Assurance, Health Care | 1 | 2008 | 124 | 0.270 |
Why?
|
| Aged, 80 and over | 5 | 2017 | 1925 | 0.270 |
Why?
|
| Retrospective Studies | 8 | 2024 | 2415 | 0.270 |
Why?
|
| Animals | 2 | 2025 | 280 | 0.270 |
Why?
|
| Health Promotion | 1 | 2008 | 279 | 0.240 |
Why?
|
| Erythrocytes | 1 | 2025 | 8 | 0.240 |
Why?
|
| Trastuzumab | 1 | 2025 | 19 | 0.240 |
Why?
|
| Positron-Emission Tomography | 2 | 2015 | 33 | 0.240 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2025 | 9 | 0.240 |
Why?
|
| DNA Methylation | 1 | 2025 | 44 | 0.230 |
Why?
|
| Young Adult | 5 | 2025 | 2465 | 0.230 |
Why?
|
| Patient Education as Topic | 2 | 2022 | 193 | 0.230 |
Why?
|
| Community Networks | 2 | 2016 | 21 | 0.230 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2025 | 52 | 0.220 |
Why?
|
| Fixatives | 1 | 2024 | 1 | 0.220 |
Why?
|
| Vertebrates | 1 | 2024 | 1 | 0.220 |
Why?
|
| Medical Records | 2 | 2015 | 91 | 0.220 |
Why?
|
| Qualitative Research | 2 | 2023 | 260 | 0.220 |
Why?
|
| Mammography | 2 | 2015 | 168 | 0.220 |
Why?
|
| Phylogeny | 1 | 2024 | 15 | 0.220 |
Why?
|
| Health Priorities | 2 | 2020 | 24 | 0.210 |
Why?
|
| Sequence Analysis, DNA | 1 | 2024 | 32 | 0.210 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2023 | 2 | 0.210 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2024 | 367 | 0.210 |
Why?
|
| Occult Blood | 2 | 2024 | 155 | 0.210 |
Why?
|
| Cancer Survivors | 3 | 2025 | 101 | 0.210 |
Why?
|
| Pandemics | 2 | 2022 | 287 | 0.200 |
Why?
|
| Rectal Neoplasms | 1 | 2023 | 75 | 0.200 |
Why?
|
| Child | 3 | 2022 | 2403 | 0.200 |
Why?
|
| Time Factors | 4 | 2023 | 1039 | 0.190 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 163 | 0.190 |
Why?
|
| Social Class | 1 | 2022 | 116 | 0.190 |
Why?
|
| Laboratories | 1 | 2022 | 19 | 0.190 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2024 | 381 | 0.190 |
Why?
|
| Hyperkalemia | 1 | 2022 | 15 | 0.180 |
Why?
|
| Health Status Disparities | 1 | 2023 | 149 | 0.180 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 44 | 0.180 |
Why?
|
| Hip Fractures | 1 | 2022 | 71 | 0.180 |
Why?
|
| Medical Informatics | 1 | 2021 | 35 | 0.180 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2022 | 53 | 0.180 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 84 | 0.180 |
Why?
|
| Quarantine | 1 | 2021 | 10 | 0.170 |
Why?
|
| Quality Improvement | 3 | 2019 | 188 | 0.170 |
Why?
|
| Critical Pathways | 1 | 2020 | 10 | 0.170 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2022 | 109 | 0.170 |
Why?
|
| Hypertension | 1 | 2025 | 469 | 0.170 |
Why?
|
| Biomedical Research | 2 | 2020 | 76 | 0.170 |
Why?
|
| Quality Indicators, Health Care | 1 | 2022 | 125 | 0.170 |
Why?
|
| United States | 5 | 2020 | 3866 | 0.170 |
Why?
|
| Precision Medicine | 1 | 2020 | 29 | 0.170 |
Why?
|
| Risk Factors | 4 | 2025 | 3258 | 0.150 |
Why?
|
| Glomerular Filtration Rate | 1 | 2019 | 153 | 0.150 |
Why?
|
| Prevalence | 2 | 2024 | 840 | 0.140 |
Why?
|
| Fellowships and Scholarships | 1 | 2017 | 9 | 0.140 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 184 | 0.130 |
Why?
|
| Vaccination | 1 | 2022 | 688 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 56 | 0.130 |
Why?
|
| Oncologists | 1 | 2016 | 7 | 0.130 |
Why?
|
| Culture | 1 | 2016 | 30 | 0.130 |
Why?
|
| Pneumonectomy | 1 | 2016 | 6 | 0.130 |
Why?
|
| Registries | 2 | 2017 | 460 | 0.130 |
Why?
|
| Learning | 1 | 2016 | 13 | 0.130 |
Why?
|
| Sinusitis | 1 | 2016 | 18 | 0.130 |
Why?
|
| Quality of Life | 2 | 2012 | 499 | 0.130 |
Why?
|
| Patient Selection | 1 | 2017 | 176 | 0.130 |
Why?
|
| Program Evaluation | 1 | 2017 | 205 | 0.130 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 24 | 0.130 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 10 | 0.120 |
Why?
|
| Mid-Atlantic Region | 1 | 2015 | 9 | 0.120 |
Why?
|
| Sampling Studies | 1 | 2015 | 43 | 0.120 |
Why?
|
| Northwestern United States | 1 | 2015 | 53 | 0.120 |
Why?
|
| Office Visits | 1 | 2016 | 73 | 0.120 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 49 | 0.120 |
Why?
|
| Adolescent | 3 | 2025 | 3538 | 0.120 |
Why?
|
| Anxiety | 1 | 2016 | 154 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 143 | 0.110 |
Why?
|
| Papillomaviridae | 2 | 2025 | 61 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 203 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 342 | 0.110 |
Why?
|
| Odds Ratio | 1 | 2015 | 640 | 0.110 |
Why?
|
| Linear Models | 1 | 2014 | 206 | 0.110 |
Why?
|
| Hospitals, University | 1 | 2013 | 14 | 0.100 |
Why?
|
| Health Services Needs and Demand | 2 | 2016 | 87 | 0.100 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 535 | 0.100 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 202 | 0.100 |
Why?
|
| Minority Groups | 2 | 2023 | 104 | 0.100 |
Why?
|
| Patient Care Team | 1 | 2013 | 105 | 0.090 |
Why?
|
| Primary Health Care | 2 | 2016 | 726 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2016 | 2514 | 0.080 |
Why?
|
| Incidence | 2 | 2025 | 1266 | 0.070 |
Why?
|
| Nursing Research | 1 | 2008 | 2 | 0.070 |
Why?
|
| Models, Nursing | 1 | 2008 | 3 | 0.070 |
Why?
|
| National Academies of Science, Engineering, and Medicine (U.S.) Health and Medicine Division | 1 | 2008 | 5 | 0.070 |
Why?
|
| Information Services | 1 | 2008 | 12 | 0.070 |
Why?
|
| Nurse's Role | 1 | 2008 | 7 | 0.070 |
Why?
|
| Total Quality Management | 1 | 2008 | 18 | 0.070 |
Why?
|
| Comprehensive Health Care | 1 | 2008 | 8 | 0.070 |
Why?
|
| Sickness Impact Profile | 1 | 2008 | 25 | 0.070 |
Why?
|
| Patient-Centered Care | 2 | 2020 | 186 | 0.070 |
Why?
|
| Health Policy | 1 | 2008 | 109 | 0.070 |
Why?
|
| Counseling | 1 | 2008 | 174 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2025 | 52 | 0.060 |
Why?
|
| Specimen Handling | 1 | 2025 | 24 | 0.060 |
Why?
|
| Papanicolaou Test | 1 | 2024 | 37 | 0.060 |
Why?
|
| Vaginal Smears | 1 | 2024 | 47 | 0.060 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2023 | 75 | 0.050 |
Why?
|
| Medicaid | 1 | 2024 | 189 | 0.050 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2022 | 61 | 0.050 |
Why?
|
| Colonoscopy | 1 | 2024 | 257 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 312 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 243 | 0.040 |
Why?
|
| Survivorship | 1 | 2020 | 12 | 0.040 |
Why?
|
| Consensus | 1 | 2020 | 40 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2020 | 28 | 0.040 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 36 | 0.040 |
Why?
|
| Government Programs | 1 | 2020 | 12 | 0.040 |
Why?
|
| Research Personnel | 1 | 2020 | 28 | 0.040 |
Why?
|
| Disease Progression | 1 | 2019 | 259 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 674 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 437 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2019 | 207 | 0.030 |
Why?
|
| Income | 1 | 2017 | 86 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 202 | 0.030 |
Why?
|
| Comprehension | 1 | 2016 | 18 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 1151 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2016 | 78 | 0.030 |
Why?
|
| Focus Groups | 1 | 2016 | 143 | 0.030 |
Why?
|
| Health Education | 1 | 2016 | 82 | 0.030 |
Why?
|
| Prognosis | 1 | 2017 | 603 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 560 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 191 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 197 | 0.030 |
Why?
|
| Research Design | 1 | 2016 | 336 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2016 | 1160 | 0.030 |
Why?
|
Concepts
(192)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(21)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->